Peter E. Baker

FDA investigator

Appears on 11 documents from 2011 to 2017, most often at sites in California. Most often cites production record review (21 CFR 211.192).

11
Documents on file
5.5
Observations per 483
2011
First seen
2017
Most recent

What they cite most

From 60 observations

Activity by year

2011: 3, 2012: 1, 2014: 4, 2016: 2, 2017: 1

Where

California 4 · India 4 · China 3

Is Peter E. Baker coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

11 documents, newest first
FirmOpen
483 Zhejiang Hisun Pharmaceutical Co., Ltd.Jan 19, 2017 · Taizhou City, China
483 Zhejiang Huahai Phannaceutical Co. LtdNov 18, 2016 · Linhai, China
483 Zhejiang Bangli Medical Products Co., Ltd. South of YueGui Road 118, Huachuan BlockAug 17, 2016 · Yongkang City, China
483 DR. REDDY'S LABORATORIES LIMITEDNov 21, 2014 · Pydibhimavaram, India
483 Ipca Laboratories LimitedOct 17, 2014 · Indore, India
483 Ipca Laboratories LimitedJul 18, 2014 · Ratlam, India
483 BE Pharmaceuticals Private LimitedJun 12, 2014 · Paonta Sahib, India

About this profile

What does Peter E. Baker inspect?

Peter E. Baker appears on 11 documents on file covering 9 sites, most often in California.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.160 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Peter E. Baker is dated Jan 19, 2017.

FDA Investigator Peter E. Baker: 483s & Inspections · FDA Intel